Adamas Pharmaceuticals Inc Human Resources Contracts & Agreements
24 Contracts & Agreements
- Bonus & Incentive Agreements (8 contracts)
- Compensation Agreements (4)
- Consulting Agreements (7)
- Employment Agreements (1)
- Separation Agreements (1)
- Severance Agreements (3)
- Form of Performance Restricted Stock Unit Grant Notice and Award Agreement (Filed With SEC on May 10, 2021)
- Compensation arrangements with Executive Officers (Filed With SEC on February 23, 2021)
- Adamas Pharmaceuticals, Inc. Amended and Restated Executive Severance Plan (Filed With SEC on February 23, 2021)
- Extension to Separation and consulting agreement by and between Adamas Pharmaceuticals, Inc. and Rajiv Patni, dated July 15, 2020 (Filed With SEC on November 5, 2020)
- 2020 Compensation actions with respect to Non-Employee Directors (Filed With SEC on May 7, 2020)
- Separation and consulting agreement by and between Adamas Pharmaceuticals, Inc. and Rajiv Patni, dated February 25, 2020 (Filed With SEC on May 7, 2020)
- Separation and consulting agreement by and between Adamas Pharmaceuticals, Inc. and Jennifer Rhodes, dated January 9, 2020 (Filed With SEC on May 7, 2020)
- Employment Offer by and between Adamas Pharmaceuticals, Inc. and Neil F. McFarlane, dated September 12, 2019 (Filed With SEC on November 7, 2019)
- Transition, separation, and consulting agreement by and between Adamas Pharmaceuticals, Inc. and Gregory T. Went, Ph.D., dated September 11, 2019 (Filed With SEC on November 7, 2019)
- Separation and consulting agreement by and between Adamas Pharmaceuticals, Inc. and Alfred G. Merriweather, dated August 7, 2019 (Filed With SEC on November 7, 2019)
- Separation and consulting agreement by and between the registrant and Richard A. King, dated September 13, 2018 (Filed With SEC on November 1, 2018)
- 2018 compensation actions with respect to Non-Employee Directors (Filed With SEC on August 2, 2018)
- Separation Agreement by and between the registrant and William Dawson, dated June 27, 2017 (Filed With SEC on August 8, 2017)
- Amended and Restated Adamas Pharmaceuticals, Inc. Executive Severance Plan (Filed With SEC on May 9, 2017)
- 2017 Executive Cash Bonus Award Program (Filed With SEC on April 5, 2017)
- AnnualAnnualChairMemberCommitteeFeeFeeAudit Committee$15,000 $7,500 Compensation Committee$10,000 $5,000 Nominating and Corporate Governance Committee$7,000 $3,500 Development... (Filed With SEC on February 28, 2017)
- CONSULTING SERVICES AGREEMENT (Filed With SEC on November 3, 2016)
- 2016 Executive Cash Bonus Award Program (Filed With SEC on May 10, 2016)
- ADAMAS PHARMACEUTICALS, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2014 EQUITY INCENTIVE PLAN) (Filed With SEC on February 23, 2016)
- ADAMAS PHARMACEUTICALS INC. 2014 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on August 11, 2015)
- ADAMAS PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: FEBRUARY 20, 2014 APPROVED BY THE STOCKHOLDERS: MARCH 23, 2014 IPO DATE/EFFECTIVE DATE:... (Filed With SEC on April 7, 2014)
- Adamas Pharmaceuticals, Inc. Executive Severance Plan (Filed With SEC on March 5, 2014)
- ADAMAS PHARMACEUTICALS, INC. TRANSACTION BONUS PLAN (Filed With SEC on March 5, 2014)
- ADAMAS PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: FEBRUARY 20, 2014 APPROVED BY THE STOCKHOLDERS: , 2014 IPO DATE/EFFECTIVE DATE: , 2014 (Filed With SEC on March 5, 2014)
